イスラエルで最高の血管造影検査医師 - トップ4名の医師

Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.

• Served as the Head of the Hematology Division at Tel Aviv University.
• Treats complex cases of leukemia, lymphoma, and rare pediatric cancers.
• Member of the American Society of Hematology and European Group for Blood and Marrow Transplantation.
• Collaborates on research with the NIH and St. Jude Children’s Research Hospital.

Dr. Zvi Cohen is the Director of the Neurosurgery Department at Sheba Medical Center. He was recently recognized in Forbes Israel’s Best Doctors list for 2025. Dr. Cohen specializes in treating complex brain, pituitary, and spinal cord tumors. He founded the brain tumor tissue bank at Sheba to support oncological research. Dr. Cohen is board-certified in neurosurgery and leads clinical trials for malignant brain tumors.

• Completed fellowships in neurosurgical oncology at MD Anderson and neuroradiology at Beth Israel.
• Expert in intraoperative MRI, stereotactic biopsies, and image-guided resections.
• Performs radiosurgery and minimally invasive microsurgery for CNS tumors.
• Member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

この医師は、15年以上の経験を持つ熟練したインターベンション心臓専門医です。ロンドン大学でMBBSを取得し、シンガポール国立大学でM.Medを取得しています。さらに、英国でMRCPの認定を受けています。この医師は、シンガポール医学アカデミーやアメリカ心臓病学会を含むいくつかの著名な組織のメンバーです。多くの論文や出版物を著しています。卓越性が認められ、2017年にHealthcare Manpower Development Plan賞を受賞し、2016年にはNUH Quality Improvement Project Merit Awardを受賞しました。